Crain's Daily Gist

04/24/19: FDA Blesses AbbVie's New Drug

Episode Summary

Today on Crain's Daily Gist, host Amy Guth talks with Crain's health care reporter Stephanie Goldberg about Chicago-based pharmaceutical company AbbVie and its new drug approved by the FDA. Plus: Boeing suspends its forecast on the grounding of the 737 Max, McDonald's turns up the pressure on Uber ahead of its IPO, Ford joins Amazon in investing in electric truck maker Rivian, Chicago's crypto industry takes a hit, and local entrepreneur Marc Bushala drops plans for a craft spirits business in the West Loop, planning to open event space instead. Follow host Amy Guth on Twitter @AmyGuth, and continue the conversation with #CrainsDailyGist.